Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Shares Issued
Ratios

SELLAS Life Sciences (SLS) Gross Profit (2020 - 2022)

SELLAS Life Sciences (SLS) has disclosed Gross Profit for 3 consecutive years, with $900000.0 as the latest value for Q1 2022.

  • Quarterly Gross Profit fell 83.93% to $900000.0 in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $900000.0 through Dec 2022, down 87.84% year-over-year, with the annual reading at $900000.0 for FY2022, 87.84% down from the prior year.
  • Gross Profit for Q1 2022 was $900000.0 at SELLAS Life Sciences, down from $1.8 million in the prior quarter.
  • The five-year high for Gross Profit was $5.6 million in Q1 2021, with the low at $900000.0 in Q1 2022.
  • Average Gross Profit over 3 years is $2.6 million, with a median of $1.8 million recorded in 2020.
  • Peak annual rise in Gross Profit hit 83.93% in 2022, while the deepest fall reached 83.93% in 2022.
  • Over 3 years, Gross Profit stood at $1.9 million in 2020, then fell by 5.26% to $1.8 million in 2021, then tumbled by 50.0% to $900000.0 in 2022.
  • According to Business Quant data, Gross Profit over the past three periods came in at $900000.0, $1.8 million, and $5.6 million for Q1 2022, Q2 2021, and Q1 2021 respectively.